Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Preliminary data from human studies on gimatecan reported in Orlando

May 30, 2002

Wilex and Aventis sponsor phase III trial in high-risk breast cancer

May 30, 2002

Endostatin enters phase II trial in stage IV metastatic melanoma

May 30, 2002

Eligard 7.5 mg launched for advanced prostate cancer

May 29, 2002

Data from basic and clinical studies on prostate cancer reported at AUA

May 29, 2002

Antitumor effects of COX and 5-LO inhibitors under evaluation by several research groups

May 29, 2002

New approaches to bladder cancer management discussed in Orlando this week

May 29, 2002

Medarex acquires anticancer and immunotherapeutic programs from Corixa

May 29, 2002

Novel dual mechanism of action reported for CP-248

May 29, 2002

CCI-779 well tolerated and active in renal cell carcinoma

May 28, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 22, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...
Saniona reports preclinical data for SAN-2668
BioWorld Science
Saniona AB has presented preclinical data and its clinical development strategy for its lead clinical candidate, SAN-2668, which is a GABA-A receptor positive...
CC-3 antibody shows antitumoral activity in penile cancer
BioWorld Science
Advanced penile cancer (PeCa) is a rare cancer affecting the genitourinary tract with a 5-year survival rate of about 10% when metastatic. First-line therapies...